S-MDI-01 Respiratory Aerosol Chamber

Medication inhalation devices for patients with respiratory diseases of all ages.

Features

FAQ

A: Who are we?

Q: Qingdao Future Medical Technology Co., Ltd. was founded in 2014. As a national high-tech enterprise in China, our business is global and closely tied to digital solutions for chronic respiratory diseases. Our innovative devices are playing an important role in the treatment of upper and lower airway diseases.

A: What certificates do you have? Which markets can you you sell?

Q: We have US FDA,CE certificates. We already sold our products in USA, Latin America,Europe, Asia,Middle East.

A: Can you do the desire and custom work for me?

Q: We can offer both OEM and ODM service according to customers’ request.

A: What other services can we provide?

Q: Accepted Delivery Terms: FOB,CFR,CIF,EXW,DDP,Express Delivery；

Accepted Payment Currency:USD,CNY;
Accepted Payment Type: T/T,L/C,D/P D/A,PayPal,Western Union,Cash;
Language Spoken:English,Chines

 Company Profile 

Yirdoc is a leading innovator in customized mesh nebulizers for inhalation therapy, offering patented technology and digital solutions to optimize delivery and maximize dose efficiency. Our expertise extends across small molecules and biologics, including LNP-encapsulated mRNA, peptides, antibodies, and exosomes, making us a pivotal partner in the biopharmaceutical industry. With a proven track record in enhancing clinical outcomes and supporting formulation development, Yirdoc delivers tailored solutions that meet the unique needs of our clients. We empower partners to navigate drug delivery complexities, ensuring their therapies achieve optimal results.

Yirdoc has operations in 3 locations and has partnered with a number of leading biopharmaceutical companies across the globe and has exported its products to more than 40 countries, including the USA, EU countries, Australia, South Korea India, Saudi Arabia, and many others.

 Our Location